Business of the House

Jeremy Lefroy Excerpts

Thursday 16th July 2015 Commons Chamber

[Chris Grayling]

We can safely assume that the Ministry of Defence, under the high-quality leadership of the current Secretary of State, looks to make sure that it maximises the value of its budget. I am pleased that we will maintain our 2% commitment to NATO, but that does not mean that the Secretary of State will not look to drive out extra efficiencies to ensure that we put as much resource as possible into the front line.

[Jeremy Lefroy (Stafford) (Con)]

BCG is an important ingredient in drugs to tackle bladder cancer, but there is a shortage and only one manufacturer of it—MSD, which to its credit is producing as much as it can. Several other manufacturers have left that particular business. May we have a debate on ensuring the security of the supply of those most vital drugs?

[Chris Grayling]

I commend my hon. Friend for the work he has done in this important area. He is a great champion for the health service in his constituency and for his constituents who need healthcare. I will make sure that the Secretary of State for Health is aware of the concerns my hon. Friend raises, and gives him a response before we come back in September.